| Literature DB >> 34156433 |
Sunnia Rajput1, Marc-Antoine Sani1,2, David W Keizer1, Frances Separovic1,2.
Abstract
Alzheimer's disease (AD) is a common neurodegenerative condition that involves the extracellular accumulation of amyloid plaques predominantly consisting of Aβ peptide aggregates. The amyloid plaques and soluble oligomeric species of Aβ are believed to be the major cause of synaptic dysfunction in AD brain and their cytotoxic mechanisms have been proposed to involve interactions with cell membranes. In this review, we discuss our solid-state nuclear magnetic resonance (ssNMR) studies of Aβ interactions with model membranes.Entities:
Keywords: Alzheimers disease; NMR spectroscopy; amyloid beta; membranes; phospholipids
Mesh:
Substances:
Year: 2021 PMID: 34156433 PMCID: PMC8286822 DOI: 10.1042/BST20201244
Source DB: PubMed Journal: Biochem Soc Trans ISSN: 0300-5127 Impact factor: 5.407
Figure 1.(A) The amyloidogenic pathway leading to the production of (B) amyloid peptide fragments of the amyloid protein precursor (APP). (C) Study of the peptide polymorphism in interaction with lipid membranes has been investigated using solid-state NMR [4].
Figure 2.(A) 13C and 15N labelled Aβ peptides exhibit beta-sheet fibril [39] or disordered aggregate structure in model membrane environment, respectively. (B) The impact of Aβ peptides on the membrane has been monitored using 31P or 2H NMR leading to valuable insights into specific perturbations, such as the presence of copper, on the lipid headgroups and acyl chains, respectively [40].